Clinical Trial Update: Tomosynthesis as Primary Test for Breast Cancer Screening [NA]

View source ↗

Summary

A clinical trial is evaluating tomosynthesis as the primary screening test for breast cancer. The study, sponsored by Azienda USL Reggio Emilia - IRCCS, is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Breast Cancer | NA | Status: ACTIVE_NOT_RECRUITING